← Back to Search

Behavioral Intervention

Web-based psychoeducational Resource for Idiopathic Hypersomnia

N/A

Recruiting

Led By Eric Zhou, PhD

Research Sponsored by Boston Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adolescent between 10-19 years of age and parent of the adolescent

Adolescent has physician-diagnosed narcolepsy type 1 or type 2, or idiopathic hypersomnia

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks

Awards & highlights

Study Summary

This trial aims to test a website that provides information for teenagers with sleeping disorders and their families. The researchers want to see if the website is easy to use, well-liked, and practical, and

Who is the study for?

This trial is for adolescents aged 10-19 with narcolepsy type 1 or type 2, or idiopathic hypersomnia, and their parents. Participants must speak English fluently and be interested in improving social health for those with central disorders of hypersomnolence.Check my eligibility

What is being tested?

The study is testing a web-based psychoeducational resource designed to help teenagers with excessive sleepiness disorders and their families. It aims to evaluate the website's user-friendliness, acceptance, practicality, and its impact on the teens' social relationships.See study design

What are the potential side effects?

Since this intervention involves educational content rather than medication, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses to the material.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 10-19 years old, or I am the parent of an adolescent in this age range.

Select...

I am a teenager diagnosed with narcolepsy or idiopathic hypersomnia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability (Enrollment)

Acceptability (Recommend Website)

Acceptability (Satisfaction)

+3 more

Secondary outcome measures

Relationship Quality

Social Problems (Loneliness)

Social Problems (Social Relationships)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Web-based psychoeducational ResourceExperimental Treatment1 Intervention

Eligible families will be provided with website access instructions. Parents and children will be instructed to review the materials separately. The intervention will provide each person with individualized action items to be discussed as a family. It is anticipated that reviewing all of the psychoeducational materials will take the parent/child approximately one hour, resulting in a total intervention burden of two hours for the family. Participants will be encouraged to return to the website as often as needed to review content. For the purposes of this project, they will be instructed to review all intervention materials within one month of receiving the website access instructions.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor

761 Previous Clinical Trials

5,579,885 Total Patients Enrolled

American Academy of Sleep MedicineOTHER

22 Previous Clinical Trials

2,593 Total Patients Enrolled

1 Trials studying Idiopathic Hypersomnia

44 Patients Enrolled for Idiopathic Hypersomnia

Eric Zhou, PhDPrincipal InvestigatorBoston Children's Hospital

3 Previous Clinical Trials

68 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study currently open for enrollment?

"As per clinicaltrials.gov, this specific medical trial is presently not open for patient enrollment. The trial information was initially made public on March 1st, 2024 and last updated on February 8th, 2024. Despite the current inactivity of this study, there are currently 25 alternative clinical trials welcoming patients seeking treatment opportunities."

Answered by AI